Abstract
Introduction
Transplantation of primary human hepatocytes is a promising approach for treating certain liver diseases like metabolic disorders as well as chronic or acute liver failure [1, 2] [3, 4] .
. So far, liver transplantation still remains the gold standard for most liver diseases. However, its applicability is restricted by the shortage of donor organs. Cell transplantation is less invasive than wholeorgan transplantation, provides an option for treating multiple patients with single-donor organs and allows for the utilization of autologous tissue for hepatocyte isolation
Hepatocyte transplantation is based on the application of cells in suspension [5] . The preparation of primary human hepatocytes for cell transplantation requires either isolation from freshly resected liver tissue, thawing of cryopreserved cells or resuspension of temporary cultivated cells. Applying the cells via the portal vein, the splenic artery or into the splenic parenchyma can lead to reorganization in the spleen (hepatization) or integration into the liver parenchyma [1] . However, a method for monitoring the processes during and following hepatocyte transplantation is still lacking. In clinical trials of hepatocyte transplantation, either the biopsies were taken from the target organ or the donor hepatocytes were visualized by radioisotope imaging [6, 7] .
Both methods show limitations regarding the safety for the patient and the long-term analysis of the transplanted cells and cannot fully address the concern of distinct localization of the cells. Recent studies have shown that magnetic resonance imaging (MRI)
might be a suitable option to solve these problems [8] .
MRI enables the non-invasive assessment and visualization of anatomy with very high spatial resolution and excellent soft tissue contrast. Compared to other non-invasive visualization strategies, such as computer tomography or scintigraphy, MRI requires no gamma-or X-ray exposition. Therefore, this method provides advanced safety to the patient and enables real-time and repetitive examinations as well as intra-operative cell tracking.
Most strategies for MRI of single cells are based on labelling with superparamagnetic iron oxide particles (SPIOs) [8] [9] [10] [11] . These particles are commercially available in different sizes and some are already approved for clinical use [12] . Experiments on cell labelling using nano-sized SPIOs have shown their detectability after in vivo accumulation by clinical MR equipment [13, 14] . Recently, the first experiences with in vitro MRI of primary human hepatocytes using SPIOs have been reported [15] . Although SPIOs are widely used for cell imaging, it has to be considered that large numbers of nano-sized particles must be incorporated into the targeted cells to enable their detection by MRI [16, 17] . Further limitations are the slow incorporation of unmodified SPIOs and their instability, which can cause a loss in detection and cytotoxicity [16] .
In order to achieve fast labelling, high safety of the particle load and detectability of the labelled cells on a single-cell level, micronsized iron oxide particles (MPIO) were introduced to cellular imaging [18] . Various cell types have been labelled with these particles, including macrophages and different human tumour cell lines, clearly proving the detectability of MPIO-labelled cells on a singlecell level [16] [17] [18] [19] [20] [21] [22] [23] [24] . However, the feasibility of using MPIO- 
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Concentration and time dependency of particle uptake
The dose-determining experiments clearly revealed the dependency of the particle uptake on the concentration of MPIOs during incubation. When the hepatocytes were incubated with increasing concentrations of MPIOs for 18 hrs, the number of particles per cell increased from 10 to 25 (Fig. 1A) . The labelling efficiency showed similar characteristics (79.50 Ϯ 7.33%-100.00%). As assessed by light microscopy, the particles were distributed throughout the entire cytoplasm of the cells and partially formed clusters of about three to five particles (Fig. 2) . The incubation with MPIOs for 2-8 hrs at a concentration of 30 particles/cell showed a dependency of both particle uptake and labelling efficiency on the incubation time. After 18 hrs of pre-culture, the particle load increased from 12 to 22, while the labelling efficiency reached a plateau of approximately 100% after 4 hrs of incubation (Fig. 1B) Fluorescence microscopy revealed the intracellular localization of the particles and showed no morphological alternations due to the particle uptake (Fig. 3A-D) . Electron microscopy confirmed the incorporation of the particles, both as single particles and as clusters. The encasement of the particles within the cytoplasmic vesicles as well as their iron core was clearly detectable (Fig. 3E) .
In (Fig. 4E and F) or 25 Ϯ 2 particles (Fig. 4G and H) [16] [17] [18] [19] [20] [21] [22] [23] [24] , an uptake of about 17-20 particles per cell (Fig. 5A and B ) was assumed to be sufficient for cell detection with MR equipment at 3.0 Tesla.
This particle load was achieved by incubating the hepatocytes with 30 particles/cell. The agarose samples containing cells with
Fig. 2 Light microscopy of native (A, B) and labelled hepatocytes (C, D). MPIOs were clearly visible within the cytoplasm of the hepatocytes, both as single particles (*) and as clusters (**). Morphological differences were not detected between native and labelled cells. Pictures were taken at 200ϫ magnification using phase contrast (A, C) and transmitted light (B, D).
Fig. 3 Fluorescence and electron microscopy of MPIO-labelled primary human hepatocytes. Cells were stained against cytokeratine 18 (A) and nuclei (B). Dragon Green labelled MPIOs (C) were distributed throughout the cytoplasm. In the overlay (D), cytokeratine 18 is illustrated as red, nuclei as blue and MPIOs as green. Electron microscopy of single hepatocytes proved the intracellular localization of the particles, both as single particles and as clusters (E).
10 Ϯ 2 ( Fig. 4A and B (Fig. 5C and D Fig. 2A and B) . They presented a polygonal shape, granular cytoplasm with vesicular inclusions and one or more nuclei. The labelling procedure caused no alternations in the morphology of the hepatocytes (Fig. 2C and D) . Shortly after incubation, the particles were situated on the cell membrane; at later timepoints, they were detected mostly in the peri-nuclear cytoplasm, both as single particles as well as clusters. Over the entire culture period, no morphological differences were seen among the four groups. (Fig. 6A) showed a rapid increase thereafter (Fig. 6B) . From day 3 until day 6, the mean urea synthesis in the groups varied between 1.4 mM/l and 1.8 mM/l per day and showed no significant differences among the groups. Albumin secretion increased during the culture period in all groups and did not show significant differences within the four groups at any time-point of measurement (Fig. 6C) [27] . The visualization of human hepatocytes via MRI requires their labelling with SPIOs [8] . In previous studies, nano-sized MagForce particles were used for this purpose [15] [25] . Cultured primary hepatocytes undergo dedifferentiation as a function of the cultivation time [29] . Previous experiments showed that the morphology and metabolic activity of the primary human hepatocytes rapidly decrease after a period of 5-7 days [25] . Therefore [17] [18] [19] 22] . As supposed by other authors, the stability and biocompatibility of the polymer shell of the MPIOs is considered to prevent degradation by intracellular lysosomes, reducing the risk of oxidative stress and cell damage by iron toxicity [16, 22, 24] 
) or an equivalent amount of MPIOs without cells (Fig. 5E and F) had a uniform appearance and revealed no distinct signal extinctions. According to these data, the concentration of 30 particles/cell and an incubation time of 4 hrs resulting in a mean particle load of 18 were defined as the standard conditions for further cell-labelling experiments.
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culture period, verifying the same amount of cells in the different groups (data not shown). In both resuspension groups, a peak in AST release was observed 24 hrs after trypsin treatment, followed by a rapid decrease from 106.8 U/L (group C) and 113.4 U/L (group D) to 36.0 U/L and 38.4 U/L on the next day, respectively
